Results 201 to 210 of about 2,286,378 (300)

Radiopharmaceutical application of TRK-950, an anti-CAPRIN-1 therapeutic antibody. [PDF]

J Cancer Res Clin Oncol
Majima Y, Kryza D, Sanada M, Sidi-Boumedine J, Mehlen P, Gibert B, Blay JY, Okano F.   +7 more
europepmc   +1 more source

A case of quadruple wild-type gastrointestinal stromal tumor with CDC42BPB::NTRK3 fusion and abundant lymphoid infiltration. [PDF]

Diagn Pathol
Xiang W, Yuan W, Ren L, Huang W, Liang H, Huang J, Luan L, Xu C, Hou Y.   +8 more
europepmc   +1 more source

Primary pancreas NTRK-rearranged neoplasm harboring an EVT6::NTRK3 fusion with a sclerosing epithelioid fibrosarcoma morphology: a case report and comprehensive review of the literature. [PDF]

Front Oncol
Wu X, Li D, Fu F, Lian L.
europepmc   +1 more source

The ontogeny of visual lateralization in pigeons might underlie miRNA-regulated Trk receptor expression

, 2019
Stephanie Lor, Verena Theis, Dirk Moser, Robert Kumsta, Carsten Theiß, Onur Güntürkün   +5 more
openalex   +1 more source

Role of TRKC and NT-3 proteins in the progression and prognosis of colorectal cancer. [PDF]

Transl Cancer Res
Chen S, Rao Y, Liu W, Yang Q, Wu G, Wu F, Gao Y, Li J, Fu J.   +8 more
europepmc   +1 more source

Dysregulated tropomyosin receptor kinase (Trk) signalling in CYLD mutant tumours

, 2010
Neil Rajan, Richard Elliott, C.J. Lord, Oliver Clewes, John Burn, Maya Sieber‐Blum, Alan Ashworth   +6 more
openalex   +1 more source

Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors. [PDF]

Cancer Res Commun
Cassier PA, Borad MJ, Sharma S, Dubois B, Caux C, Okano F, Von Hoff DD, Blay JY.   +7 more
europepmc   +1 more source

Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer. [PDF]

ESMO Open
Hong DS, Xu RH, Shen L, Dierselhuis MP, Orbach D, McDermott R, Italiano A, Tahara M, Bernard-Gauthier V, Neu N, Mussi CE, De La Cuesta E, Laetsch TW, Drilon A.   +13 more
europepmc   +1 more source

Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluRI) and Trk receptor activation is mediated via phospholipase C signalling pathways

EMBO Journal, 2001
M. Canossa, A. Gärtner, G. Campana, N. Inagaki, H. Thoenen   +4 more
semanticscholar   +1 more source

Resumen de tesis. Desubiquitinasas moduladoras de receptores Trk

, 2019
[ES] Partiendo de un ensayo de identificación de posibles desubiquitinasas implicadas en la señalización del receptor TrkA, seleccionamos ocho para realizar estudios adicionales. De estas ocho, elegimos dos para estudiar en profundidad su papel en la ubiquitinación de los receptores TrkA y TrkB.
openaire   +1 more source